The DOI matches its Crossref record; 108 of the 116 references it cites were found in a registry or an index; none of the 89 sources its claims cite is checked for support yet.
The Pathogenesis of Adenomyosis vis-à-vis Endometriosis
Open accessAbstract
Adenomyosis is used to be called endometriosis interna, and deep endometriosis is now called adenomyosis externa. Thus, there is a question as to whether adenomyosis is simply endometriosis of the uterus, either from the perspective of pathogenesis or pathophysiology. In this manuscript, a comprehensive review was performed with a literature search using PubMed for all publications in English, related to adenomyosis and endometriosis, from inception to June 20, 2019. In addition, two prevailing theories, i.e., invagination—based on tissue injury and repair (TIAR) hypothesis—and metaplasia, on adenomyosis pathogenesis, are briefly overviewed and then critically scrutinized. Both theories have apparent limitations, i.e., difficulty in falsification, explaining existing data, and making useful predictions. Based on the current understanding of wound healing, a new hypothesis, called endometrial-myometrial interface disruption (EMID), is proposed to account for adenomyosis resulting from iatrogenic trauma to EMI. The EMID hypothesis not only highlights the more salient feature, i.e., hypoxia, at the wounding site, but also incorporates epithelial mesenchymal transition, recruitment of bone-marrow-derived stem cells, and enhanced survival and dissemination of endometrial cells dispersed and displaced due to iatrogenic procedures. More importantly, the EMID hypothesis predicts that the risk of adenomyosis can be reduced if certain perioperative interventions are performed. Consequently, from a pathogenic standpoint, adenomyosis is not simply endometriosis of the uterus, and, as such, may call for interventional procedures that are somewhat different from those for endometriosis to achieve the best results.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This review argues that adenomyosis is not simply endometriosis of the uterus, because the two conditions have different risk profiles, age-specific incidence, and likely pathogenesis. It critiques the invagination/TIAR and metaplasia theories and proposes the endometrial–myometrial interface disruption (EMID) hypothesis, centered on iatrogenic trauma, hypoxia, EMT, and bone-marrow-derived stem cell recruitment.
Key findings
- Reported adenomyosis prevalence varies widely, from 10% to 57%; in a population-based study in Northeast Italy, estimated prevalence was 0.18% for adenomyosis versus 1.14% for endometriosis, with adenomyosis incidence peaking at ages 46–50 years.
- Parity is consistently a risk factor for adenomyosis, smoking is inconsistently protective, and a history of dilatation and curettage (D&C) is suggested as a risk factor; this risk profile differs from endometriosis, where greater parity is protective and earlier menarche/shorter menstrual cycles are risk factors.
- The review criticizes both prevailing adenomyosis theories—invagination/TIAR and metaplasia—as difficult to falsify, unable to fully explain existing data, and limited in making useful predictions; it notes the TIAR feed-forward loop is based almost exclusively on endometriotic stromal cells, whereas normal endometrial stromal cells have hypermethylated/silenced aromatase, SF-1, and ERβ.
- The proposed EMID hypothesis holds that iatrogenic trauma to the endometrial–myometrial interface causes hypoxia, platelet aggregation, increased estrogen production, TGF-β1/VEGF/PDGF/COX-2/SDF-1 signaling, elevated PGE2, EMT, bone-marrow-derived stem cell recruitment, and impaired cell-mediated immunity, promoting survival and myometrial implantation of displaced endometrial cells; it predicts perioperative interventions may reduce adenomyosis risk.
Methods
- Comprehensive review with a PubMed literature search for all English publications related to adenomyosis and endometriosis from inception to June 20, 2019.
- Briefly overviews and critically scrutinizes the two prevailing adenomyosis pathogenesis theories—invagination/TIAR and metaplasia—then proposes the EMID hypothesis based on current understanding of wound healing.
- No primary experimental data are reported in this review; it mentions that EMID can robustly induce adenomyosis in mice (Hao et al., submitted for publication) as cited/unpublished evidence.
Limitations
- The paper states the EMID hypothesis may account for adenomyosis arising from iatrogenic trauma and perhaps persistent hyperperistalsis-induced EMID, but probably not focal adenomyosis of the outer myometrium (FAOM) or extrinsic/exterior adenomyosis.
- The paper states the model is by no means final or complete and is subject to change or modification; other aiders and abettors may yet be identified, and upstream cues or risk factors for hyperperistalsis-induced EMID need elucidation.
- Evident from the text: as a narrative review, it does not report a systematic review protocol, risk-of-bias assessment, or meta-analysis, and the mouse induction evidence is cited as submitted/unpublished rather than detailed in the paper.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 89 cited sources checked · 0 supported · 0 flagged
In the paper
“In fact, EMID can robustly induce adenomyosis in mice (Hao et al., submitted for publication).”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.4. Revamping the TIAR Theory: The Endometrial-Myometrial Interface Disruption (EMID)
What the sources say
- Not checked yetcites Hao et al., submitted for publication
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“This wide variability stems from variations in the histological criteria adopted for diagnosis and the techniques used to procure myometrial samples [15].”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 2. Epidemiology
What the sources say
- Not checked yetcites [15] Vercellini, 2006, Adenomyosis, epidemiological factors, Best Pr. Res. Clin. Obs. Gynaecol. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“A preponderance of evidence suggests that a history of receiving dilatation and curettage (D&C) procedures is a risk factor for adenomyosis [19,20,21,22].”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 2. Epidemiology
What the sources say
- Not checked yetcites [19] Parazzini, 1997, Risk factors for adenomyosis, Hum. Reprod source
- Not checked yetcites [20] Levgur, 2000, Adenomyosis, symptoms, histology, and pregnancy terminations, Obs. Gynecol.
- Not checked yetcites [21] Curtis, 2002, Disruption of the endometrial-myometrial border during pregnancy as a risk factor for adenomyosis, Am. J. Obs. Gynecol. source
- Not checked yetcites [22] Panganamamula, 2004, Is prior uterine surgery a risk factor for adenomyosis?, Obs. Gynecol. source
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The different risk profiles and the different age-specific incidence between the two diseases indicate that they are likely to have different pathogenesis.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 2. Epidemiology
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Even in women with leiomyomas, women with both leiomyomas and adenomyosis are reported to be older than those with leiomyomas alone [24].”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 2. Epidemiology
What the sources say
- Not checked yetcites [24] Brucker, 2014, Clinical characteristics indicating adenomyosis coexisting with leiomyomas, a retrospective, questionnaire-based study, Fertil. Steril. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“The age-specific incidence of adenomyosis is very different from that of endometriosis, reaching its peak at the age interval of 46–50 years [17].”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 2. Epidemiology
What the sources say
- Not checked yetcites [17] Morassutto, C., Monasta, L., Ricci, G., Barbone, F., and Ronfani, L. (2016). Incidence and Estimated Prevalence of Endometriosis and Adenomyosis in Northeast Italy, A Data Linkage Study. PLoS ONE, 11. source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“In particular, neonatal exposure to diethylstilbestrol followed by continuous hormonal treatment—even progesterone alone—also results in adenomyosis [58].”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.3. The TIAR Theory: The Need for Patching up
What the sources say
- Not checked yetcites [58] Ostrander, 1985, Long-term responses of the mouse uterus to neonatal diethylstilbestrol treatment and to later sex hormone exposure, J. Natl. Cancer Inst.
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Yet normal endometrial stromal cells are very different in behavior from endometriotic or even adenomyotic stromal cells.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.3. The TIAR Theory: The Need for Patching up
What the sources say
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Consequent to vascular damage, activated platelets can also release an array of cellular growth factors and angiogenic factors such as PDGF and VEGF, as well as inflammatory mediators such as IL-8 [79,80,81].”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.4. Revamping the TIAR Theory: The Endometrial-Myometrial Interface Disruption (EMID)
What the sources say
- Not checked yetcites [79] Holt, 1985, Biochemistry of alpha granule proteins, Semin. Hematol.
- Not checked yetcites [80] Gear, 2003, Platelet chemokines and chemokine receptors, linking hemostasis, inflammation, and host defense, Microcirculation source
- Not checked yetcites [81] Wagner, 2003, Platelets in inflammation and thrombosis, Arter. Thromb. Vasc. Biol. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In iatrogenic trauma such as the D&C procedure, the injury to the endometrium can probably extend to the EMI.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.4. Revamping the TIAR Theory: The Endometrial-Myometrial Interface Disruption (EMID)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclear
- It may state two separate claims as one. 31
- Probably not a substantial claim. 15
In the paper
“Sampson’s retrograde menstruation theory is the most widely accepted and has the most robust evidence [27].”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis
What the sources say
- Not checked yetcites [27] Vercellini, 2014, Endometriosis, pathogenesis and treatment, Nat. Rev. Endocrinol. source
Strength:boosted· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The D&C procedure, and perhaps other uterine surgeries as well, may disrupt the endometrial–myometrial interface (EMI) and facilitate the invasion, implantation, embedding, and establishment of endometrial colonies within the myometrial wall, increasing the risk of adenomyosis.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 2. Epidemiology
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In a rare population-based study, the estimated prevalence of adenomyosis in Northeast Italy is reported to be 0.18%, much lower than that of endometriosis (1.14%) [17].”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 2. Epidemiology
What the sources say
- Not checked yetcites [17] Morassutto, C., Monasta, L., Ricci, G., Barbone, F., and Ronfani, L. (2016). Incidence and Estimated Prevalence of Endometriosis and Adenomyosis in Northeast Italy, A Data Linkage Study. PLoS ONE, 11. source
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Parity is consistently shown to be a risk factor, while smoking is inconsistently shown to be a protective factor [15,18].”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 2. Epidemiology
What the sources say
- Not checked yetcites [15] Vercellini, 2006, Adenomyosis, epidemiological factors, Best Pr. Res. Clin. Obs. Gynaecol. source
- Not checked yetcites [18] Taran, 2013, Adenomyosis, Epidemiology, Risk Factors, Clinical Phenotype and Surgical and Interventional Alternatives to Hysterectomy, Geburtshilfe Frauenheilkd source
Strength:boosted· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Aside from their similar symptomologies, both are estrogen-dependent [10] and share many molecular aberrations.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 1. Introduction
What the sources say
- Not checked yetcites [10] Kitawaki, 2006, Adenomyosis, the pathophysiology of an oestrogen-dependent disease, Best Pr. Res. Clin. Obs. Gynaecol. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Adenomyosis, defined as the presence of endometrial glands and stroma infiltrated deep and haphazardly into the myometrium [1], is a common gynecologic disorder with poorly understood pathogenesis and pathophysiology [2,3,4].”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 1. Introduction
What the sources say
- Not checked yetcites [2] Bergeron, 2006, Pathology and physiopathology of adenomyosis, Best Pr. Res. Clin. Obs. Gynaecol. source
- Not checked yetcites [3] Vannuccini, 2017, Pathogenesis of adenomyosis, an update on molecular mechanisms, Reprod. Biomed. Online source
- Not checked yetcites [4] Donnez, 2018, Pathogenesis of uterine adenomyosis, invagination or metaplasia?, Fertil. Steril. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The definition of adenomyosis is essentially the presence of ectopic endometrium within the myometrium, very similar to that of endometriosis, which is the presence of ectopic endometrium outside of the uterine cavity.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 1. Introduction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Hence, the short answer to the question would be: adenomyosis is not simply endometriosis of the uterus; rather, it shares with endometriosis similar developmental features but probably not the causes.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 1. Introduction
Load-bearingStrength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The reported prevalence of adenomyosis varies greatly among different studies, from as low as 10% to as high as 57% [15,16].”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 2. Epidemiology
What the sources say
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“The clinical treatment strategy for the two diseases also seems to be similar, and the drugs to treat the two diseases can be used interchangeably [11].”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 1. Introduction
What the sources say
- Not checked yetcites [11] Vannuccini, 2018, Role of medical therapy in the management of uterine adenomyosis, Fertil. Steril. source
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“The risk profiles for adenomyosis are thus quite different from that of endometriosis, in which greater parity is a protective factor, while earlier age at menarche and shorter menstrual cycle length—factors that are consistent with Sampson’s retrograde menstruation theory for the etiology of endometriosis—are risk factors [23].”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 2. Epidemiology
What the sources say
- Not checked yetcites [23] Shafrir, 2018, Risk for and consequences of endometriosis, A critical epidemiologic review, Best Pract. Res. Clin. Obstet. Gynaecol. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In fact, over 1000 genes are documented to be differentially expressed between adenomyotic lesions and eutopic endometrium [65] and close to 1000 genes are differentially expressed between ectopic and eutopic endometrium [66].”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.3. The TIAR Theory: The Need for Patching up
What the sources say
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In a nutshell, they showed that uterine peristalsis is critical for sperm transport, and women with endometriosis exhibit hyperperistalsis and dysperistalsis [38,39,40,41].”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.1. Invagination
What the sources say
- Not checked yetcites [38] Leyendecker, 1996, Uterine hyperperistalsis and dysperistalsis as dysfunctions of the mechanism of rapid sperm transport in patients with endometriosis and infertility, Hum. Reprod. source
- Not checked yetcites [39] Kunz, 1996, The dynamics of rapid sperm transport through the female genital tract, evidence from vaginal sonography of uterine peristalsis and hysterosalpingoscintigraphy, Hum. Reprod. source
- Not checked yetcites [40] Kunz, 1998, Sonographic evidence for the involvement of the utero-ovarian counter-current system in the ovarian control of directed uterine sperm transport, Hum. Reprod. Update source
- Not checked yetcites [41] Wildt, 1998, Sperm transport in the human female genital tract and its modulation by oxytocin as assessed by hysterosalpingoscintigraphy, hysterotonography, electrohysterography and Doppler sonography, Hum. Reprod. Update source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In sharp contrast to endometriosis, the exact pathogenesis of adenomyosis is largely a conundrum.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis
Strength:plain· not yet calibratedTests✓ Asserted: passes✗ Checkable: fails✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. It may be too vague to check against evidence. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Both theories have apparent limitations, i.e., difficulty in falsification, explaining existing data, and making useful predictions.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > Abstract
Load-bearingStrength:hedged· not yet calibratedTests✓ Asserted: passes? Checkable: unclear✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, hyperperistalsis may induce COX-2 expression and higher PGE2 production in endometrial stromal cells, but it is unlikely to further induce increased estrogen production.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.3. The TIAR Theory: The Need for Patching up
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Indeed, the newly reported association between focal adenomyosis of the outer myometrium (FAOM) and deep endometriosis (DE) [61,62] suggests that not all subtypes of adenomyosis are the same and may have a different pathogenesis.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.3. The TIAR Theory: The Need for Patching up
What the sources say
- Not checked yetcites [61] Chapron, 2017, Relationship between the magnetic resonance imaging appearance of adenomyosis and endometriosis phenotypes, Hum. Reprod. source
- Not checked yetcites [62] Marcellin, 2018, Anterior Focal Adenomyosis and Bladder Deep Infiltrating Endometriosis, Is There a Link?, J. Minim. Invasive Gynecol. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“but inhibition of pituitary prolactin secretion during youth in mice suppressed the induction of adenomyosis [60], suggesting the potential role of prolactin in the pathogenesis of adenomyosis.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.3. The TIAR Theory: The Need for Patching up
What the sources say
- Not checked yetcites [60] Nagasawa, 1982, Stimulation of mammary tumorigenesis and suppression of uterine adenomyosis by temporary inhibition of pituitary prolactin secretion during youth in mice (41492), Proc. Soc. Exp. Biol. Med. source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“More importantly, it is difficult, if not impossible, to devise an experiment to prove or disprove either theory.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.3. The TIAR Theory: The Need for Patching up
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✗ Checkable: fails✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. It may be too vague to check against evidence. The paper may give no reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Thus, hypoxia may well be viewed as the single most important event following tissue injury, and, indeed, adaptation to hypoxic stress via HIF signaling plays a critical role in promoting wound healing processes [74,75].”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.4. Revamping the TIAR Theory: The Endometrial-Myometrial Interface Disruption (EMID)
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Hence, the injury to the EMI constitutes a trauma, leading to subsequent tissue hypoxia in myocytes and fibroblasts.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.4. Revamping the TIAR Theory: The Endometrial-Myometrial Interface Disruption (EMID)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclearIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Even though adenomyotic lesions (used to be called endometriosis interna) may resemble DE lesions (now called adenomyosis externa [107]) in their look and feel, their developmental paths may be similar but not entirely the same, due to their different microenvironment.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 4. Conclusions
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“it raises a tantalizing possibility that perioperative intervention could reduce the risk of adenomyosis, as in the case of a reduction in recurrence risk in endometriosis [100].”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.4. Revamping the TIAR Theory: The Endometrial-Myometrial Interface Disruption (EMID)
What the sources say
- Not checked yetcites [100] Long, 2019, Perioperative Intervention by beta-Blockade and NF-kappaB Suppression Reduces the Recurrence Risk of Endometriosis in Mice Due to Incomplete Excision, Reprod. Sci. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Conceivably, these surgical procedures would result in the direct implantation of endometrial cells ectopically within the abdominal wall.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.5. Similarities and Difference in Pathogenesis between Adenomyosis and Endometriosis
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Note that hypoxia-induced COX-2 overexpression can increase the production of not only PGE2 but also PGH2, which leads to increased production of thromboxane A2 (TXA2), a vasoconstrictor, a potent platelet activator, and a potent inducer of uterine contraction [99].”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.4. Revamping the TIAR Theory: The Endometrial-Myometrial Interface Disruption (EMID)
What the sources say
- Not checked yetcites [99] Wilhelmsson, 1981, PGH2, TxA2 and PGI2 have potent and differentiated actions on human uterine contractility, Prostaglandins source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The release of adrenaline/noradrenaline and PGE2 can reduce cell-mediated immunity, promoting the survival of spread and displaced endometrial cells.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.4. Revamping the TIAR Theory: The Endometrial-Myometrial Interface Disruption (EMID)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, the increased estrogen levels may induce an ERα-mediated OT/OTR system, enhancing uterine peristalsis.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.4. Revamping the TIAR Theory: The Endometrial-Myometrial Interface Disruption (EMID)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclearIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“HIF-1α-induced COX-2 expression leads to elevated PGE2 levels, which can induce PGE2-mediated vascularization [87,88].”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.4. Revamping the TIAR Theory: The Endometrial-Myometrial Interface Disruption (EMID)
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“While it can explain the genesis of adenomyosis induced by iatrogenic trauma, it may also explain the pathogenesis of adenomyosis due to persistent hyperperistalsis that causes EMID, but probably not FAOM or extrinsic/exterior adenomyosis.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.4. Revamping the TIAR Theory: The Endometrial-Myometrial Interface Disruption (EMID)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For example, perioperative intervention when iatrogenic procedures such as D&C are performed may reduce the risk of developing adenomyosis in the first place.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 4. Conclusions
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds.
In the paper
“As adenomyosis shares with endometriosis in cyclic bleeding and thus ReTIAR”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 4. Conclusions
What the sources say
- Not checked yetcites [104] Guo, 2018, Fibrogenesis resulting from cyclic bleeding, the Holy Grail of the natural history of ectopic endometrium, Hum. Reprod. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, increased estradiol levels would induce ERα, which further activate OT/OTR signaling pathway, causing increased peristalsis.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.4. Revamping the TIAR Theory: The Endometrial-Myometrial Interface Disruption (EMID)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“That adenomyosis is not simply endometriosis of the uterus implies that, when it comes to management and prevention, interventions that are carefully tailored to adenomyosis should be more effective.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 4. Conclusions
Tests✓ Asserted: passes✗ Checkable: fails✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may be too vague to check against evidence.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In fact, even for adenomyosis, there might be two or more different pathogenic origins, for example, the FAOM, or extrinsic or external adenomyosis, might originate from the invasion of neighboring DE lesions.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.5. Similarities and Difference in Pathogenesis between Adenomyosis and Endometriosis
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these catecholamines and PGE2 would impair the cell-mediated immunity, promoting the survival of displaced and dispersed cells that spread to the EMI and possibly beyond due to the procedure.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.4. Revamping the TIAR Theory: The Endometrial-Myometrial Interface Disruption (EMID)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclearIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, since uterine procedures using different energy sources result in different severities of injury and bleeding patterns, the resultant EMID would lead to differential = risk of developing adenomyosis.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.4. Revamping the TIAR Theory: The Endometrial-Myometrial Interface Disruption (EMID)
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear? Based: unclearIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The model depicted in Figure 3 is completely falsifiable.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.4. Revamping the TIAR Theory: The Endometrial-Myometrial Interface Disruption (EMID)
Strength:boosted· not yet calibratedTests✓ Asserted: passes✗ Checkable: fails✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. It may be too vague to check against evidence. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Unlike the TIAR theory, the EMID hypothesis is easily falsifiable, at least in mouse.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 4. Conclusions
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✗ Checkable: fails✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. It may be too vague to check against evidence. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, when EMID occurs, such as in the D&C procedure, the resultant tissue hypoxia would lead to platelet aggregation, increased estrogen production, induction of the TGF-β1, VEGF, PDGF, COX-2, and SDF-1 signaling and the resultant elevated PGE2 production, induction of EMT, and increased recruitment of BMDSCs in the wound site, all of which can promote the mobility and implantation of endometrial”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.4. Revamping the TIAR Theory: The Endometrial-Myometrial Interface Disruption (EMID)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, EMID may induce EMT in adjacent endometrial epithelial cells and enhance their mobility and invasiveness, resulting in the crossing of EMI to the myometrium by endometrial epithelial cells.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.4. Revamping the TIAR Theory: The Endometrial-Myometrial Interface Disruption (EMID)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For example, the use of coagulation might lead to a lower risk of adenomyosis than the D&C procedure.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.4. Revamping the TIAR Theory: The Endometrial-Myometrial Interface Disruption (EMID)
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This model can at least account for the genesis of adenomyosis arising from iatrogenic trauma such as uterine procedures, but perhaps not for adenomyosis induced by other causes.”
§ The Pathogenesis of Adenomyosis vis-à-vis Endometriosis > 3. Pathogenesis > 3.4. Revamping the TIAR Theory: The Endometrial-Myometrial Interface Disruption (EMID)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper relies on this without support.
The molecular mechanisms of wound healing in non-endometrial tissues apply to the endometrial–myometrial interface and adenomyosis pathogenesis.
“Based on the current understanding of wound healing, a new hypothesis, called endometrial-myometrial interface disruption (EMID), is proposed to account for adenomyosis resulting from iatrogenic trauma to EMI.”
The paper relies on this without support.
The mouse EMID model is a valid model for human adenomyosis.
“In fact, EMID can robustly induce adenomyosis in mice (Hao et al., submitted for publication).”
The paper relies on this without support.
Normal endometrial stromal cells studied in vitro reflect normal endometrial stromal cells in vivo.
“Yet normal endometrial stromal cells are very different in behavior from endometriotic or even adenomyotic stromal cells.”
The paper relies on this without support.
Iatrogenic procedures are common in gynecological practice nowadays.
“iatrogenic procedures aplenty nowadays in gynecological practice”
The paper relies on this without support.
Many medications used primarily for treating endometriosis can and have been used also for treating adenomyosis.
“many medications used primarily for treating endometriosis can and have been used also for treating adenomyosis”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The majority of research includes instances of gynecologic surgery for benign conditions such as adenomyosis, uterine leiomyomas, and fibroids [17,18]”
From Challenges in Diagnosis and Prevention of Iatrogenic Endometriosis as a Long-Term Surgical Complication after C-Section (2022) · cites this paper as [18]
Citations
Cites
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645 · cited 1×
“Once hypoxic, evolutionarily conserved adaptive processes, such as hypoxia-inducible factors (HIFs), are activated [73].”
BackgroundGiudice, L. C., & Kao, L. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17403-5 · Cited by 3,166
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., & Gurtner, G. C. (2004) · Nature Medicine · doi:10.1038/nm1075 · Cited by 2,600
Cyclooxygenase regulates angiogenesis induced by colon cancer cells
Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., & DuBois, R. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81433-6 · Cited by 2,272
Endometriosis: pathogenesis and treatment
Vercellini, P., Viganò, P., Somigliana, E., & Fedele, L. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.255 · Cited by 1,940 · cited 1×
“Sampson’s retrograde menstruation theory is the most widely accepted and has the most robust evidence [27].”
BackgroundPathogenesis and pathophysiology of endometriosis
Burney, R. O., & Giudice, L. C. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.06.029 · Cited by 1,590 · cited 1×
“For endometriosis, several theories regarding its pathogenesis have been proposed, and these hypotheses can be divided into three themes: in situ development (such as coelomic metaplasia or embryonic cell rests), implantation, or a combination of in situ development and implantation [25,26].”
BackgroundHIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579 · cited 2×
“Hypoxia can also enhance cellular viability and proliferation through upregulation of insulin growth factor 2 (IGF-2) and IGF binding protein 3 (IGF-BP3) [85].”
BackgroundGreenhough, A., Smartt, H. J. M., Moore, A. E., Roberts, H. R., Williams, A. C., Paraskeva, C., & Kaidi, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp014 · Cited by 1,220 · cited 1×
“HIF-1α-induced COX-2 expression leads to elevated PGE2 levels, which can induce PGE2-mediated vascularization [87,88].”
BackgroundRisk for and consequences of endometriosis: A critical epidemiologic review
Shafrir, A. L., Farland, L. V., Shah, D. K., Harris, H. R., Kvaskoff, M., Zondervan, K., & Missmer, S. A. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2018.06.001 · Cited by 823 · cited 1×
“The risk profiles for adenomyosis are thus quite different from that of endometriosis, in which greater parity is a protective factor, while earlier age at menarche and shorter menstrual cycle length—factors that are consistent with Sampson’s retrograde menstruation theory for the etiology of endometriosis—are risk fa…”
Background
Flagged first, then by citations
8 of the 116 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Lacassagne, 1935, Modifications progressive de I’uterus de la souris sous l’action prolongee de I’oestrone, C R Seances Soc. Bioi., 35, 320
Cited by
Sorted by citations
Items 101–160 of 160
Uterine Embolization as a New Treatment Option in Adenomyosis Uteri
Tsikouras, P. N., Gaitatzi, F., Filiou, S., Michalopoulos, S., Gerede, A., Tsalikidis, C., Zervoudis, S., Bothou, Α., Vatsidou, X., Chalkidou, A., et al. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101480 · Cited by 3
Rudimentary Horn Adenomyosis in A 20-Year-Old Patient With Unicornuate Uterus: A Case Report
Feghali, E. J., Daccache, A., Feghali, E., et al. (2022) · International Journal of Clinical Research · doi:10.38179/ijcr.v3i1.87 · Cited by 2
“Mullerian ducts or remnants during their fusion, which might be the case in this patient [16].”
BackgroundWomen’s experiences of the diagnostic journey in uterine adenomyosis: a scoping review protocol
Taylor, M. A., Croudace, T. J., McBride, M., & Muir, F. E. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-075316 · Cited by 1
An Update on the Various Theories of the Origin of Uterine Adenomyosis –A Systematic Review
Kaur, K. K., Allahbadia, G., & Singh, M. (2020) · Archives of Urology · doi:10.22259/2638-5228.0301004 · Cited by 2
Role of molecular signaling pathways in the pathogenesis of adenomyosis
Shalina, M. A., Yarmolinskaya, M. I., Netreba, E. A., & Beganova, A. K. (2021) · Journal of obstetrics and women s diseases · doi:10.17816/jowd57192 · Cited by 1
Endometriosis in Reproductive Years: The Origin of Pain in Endometriosis and Adenomyosis
Mechsner, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-97236-3_15 · Cited by 1
Hsu, L.-T., Lu, P., Wang, Y., Wu, H., Chen, I.-J., & Huang, H.-Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011155 · Cited by 1
“A hypothesis called EMI disruption (EMID) is also proposed to account for adenomyosis resulting from iatrogenic trauma to EMI [43].”
BackgroundKlymenko, Y., Kersey, J. L., Quigley, H. D., & Hawkins, S. M. (2025) · Biology of Reproduction · doi:10.1093/biolre/ioaf255 · Cited by 1
Xu, S., Xin, Y., Lv, F., Hu, X., & Xiao, R.-P. (2026) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/csb-2025-5885 · Cited by 1
Kahveci, B., & Kızıldemir, Y. Z. (2026) · BMC Women s Health · doi:10.1186/s12905-026-04402-5 · Cited by 1
“The focal type of these conditions usually affects the external part of the myometrium and adheres to the uterus with other structures, making surgery difficult, and may increase the risk of surgical complications [17].”
Ponomarova, I., Lisyana, T. O., Trokhymovych, О. V., et al. (2022) · Medical Research Journal · doi:10.5603/mrj.a2022.0034 · Cited by 1
“Despite the existence of various theories of uterine adenomyosis, the pathogenesis of the disease and the mechanisms of its influence on reproductive function have not been fully explored [6, 7].”
BackgroundEndometriosis and adenomyosis: common and disparate features
Deryabina, V. A., Brus, T. V., & Pyurveev, S. S. (2022) · Pediatrician (St Petersburg) · doi:10.17816/ped13581-97 · Cited by 2
Prediction of adenomyosis diagnosis based on MRI
Rees, C. O., van de Wiel, M., Nederend, J., Huppelschoten, A. G., Mischi, M., van Vliet, H. A. A. M., & Schoot, B. C. (2023) · Journal of Endometriosis and Uterine Disorders · doi:10.1016/j.jeud.2023.100028 · Cited by 1
Whole genome doubling in adenomyosis
Chao, X., Chen, X., Su, H., Shang, X., Wu, H., You, Y., Wang, S., Li, H., Li, Z., Zhu, L., et al. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1809 · Cited by 1
Valdés‐Bango, M., Azkargorta, M., Gràcia, M., Ros, C., Rius, M., Martínez‐Zamora, M. Á., de Guirior, C., Quintas, L., Elortza, F., & Carmona, F. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0004785 · Cited by 1
Pathogenese der Endometriose: Bedeutung für Schmerzentstehung und Subfertilität
Mechsner, S. (2020) · Der Gynäkologe · doi:10.1007/s00129-020-04665-5 · Cited by 2
Insights on Adenomyosis Development
Vannuccini, S., & Clemenza, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-97236-3_31 · Cited by 1
Polymorphism for Interleukin-4 (-590 C/T) Promoter: Non-Association with Endometriosis
Hairunisyah, R., & Fatimah, S. (2022) · International Journal Scientific and Professional (IJ-ChiProf) · doi:10.56988/chiprof.v1i1.2 · Cited by 1
“the Increased il-4 expression is previously noted in women with endometriosis (12,13).”
BackgroundOrmenezi, I., Ribeiro‐Silva, A., Silva, J. C. R. E., Meola, J., dos Reis, F. J. C., & Poli‐Neto, O. B. (2022) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2022e12375 · Cited by 1
“From a pathophysiological point of view, numerous processes appear to be involved in a delicately orchestrated and self-sustained cycle, including cell damage, proliferation, fibrosis, inflammation, tissue hypoxia, neuroangiogenesis, increased estrogen production, and uterine hyperperistalsis (13).”
BackgroundZeng, Y., Jia, J., Lü, J., Zeng, C., Geng, H., & Chen, Y. (2024) · PubMed Central · doi:10.12122/j.issn.1673-4254.2024.04.02 · Cited by 1
The Clinical Features and Diagnosis of Adenomyosis
Dai, Y., & Leng, J. (2021) · Springer eBooks · doi:10.1007/978-981-33-4095-4_4
Clinical case of differential diagnosis of retrocervical endometriosis
Levakov, S. A., Mamedova, A. E., Azadova, G. Y. K., & Paukov, S. V. (2021) · V F Snegirev Archives of Obstetrics and Gynecology · doi:10.17816/2313-8726-2021-8-2-109-115
Ibrahim, P. S. S., Jeyakumar, J. E., & Vinayagam, S. C. (2021) · Journal of Applied Solution Chemistry and Modeling · doi:10.6000/1929-5030.2021.10.01
PROBLEMATIC ISSUES IN THE ETIOLOGY AND PATHOGENESIS OF ADENOMYOSIS
Metreveli, B., Gagua, D., & Burkadze, G. (2021) · EXPERIMENTAL & CLINICAL MEDICINE GEORGIA · doi:10.52340/jecm.2021.391
Lin, C., Wu, M., Mau, Y., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-963721/v1
“Endometrial-myometrial interface disruption has recently been hypothesized for the pathogenesis of adenomyosis [1].”
BackgroundEvaluation of a surface treatment on the performance of Crofer 22 APU in a SOFC Button Cell
Alman, D. E., Johnson, C. D., & Jablonski, P. D. (2007) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
Endometriosis - Recent Advances, New Perspectives and Treatments
Gonçalves, G. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95742 · Cited by 1
Wang, Y., Duan, H., Wang, S., Quan, Y., Huang, J., & Guo, Z. (2021) · Research Square · doi:10.21203/rs.3.rs-181716/v1
Clinical Research Progress of Adenomyosis
席, 欣. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.12121707
Prediction of adenomyosis in patients with uterine fibroids
Shramko, S. V., Зорина, В. Н., Vlasenko, A. E., et al. (2023) · GYNECOLOGY · doi:10.26442/20795696.2023.1.201802
Differences clinical characteristics and factors in intrinsic and extrinsic adenomyosisPreprint
Liang, Y., Shi, W., Sun, F., Zhu, M., Liu, Y., & Zhang, J. (2023) · Research Square · doi:10.21203/rs.3.rs-2752816/v1
Hydroxysafflor Yellow A ameliorates adenomyosis by improving IDH1-autophagy-EMTPreprint
Li, X., Xu, Z., Wang, L., Li, X., Wu, X., Wu, X., Hong, H., Shen, Y., & Du, R. (2023) · doi:10.22541/au.168966930.03401710/v1
Cao, Y., Li, C., & Ding, D. (2024) · Research Square · doi:10.21203/rs.3.rs-4448561/v1
Catherino, W. H., As‐Sanie, S., Cozzolino, M., Marcellin, L., Missmer, S. A., Stewart, E. A., den Bosch, T. V., Chapron, C., & Petraglia, F. (2024) · F&S Science · doi:10.1016/j.xfss.2024.06.006
Classification of Endometriosis: A Systematic Review
Saremi, A. T., & Nateghi, M. R. (2022) · ملیون. · doi:10.61186/sjrm.7.3.195
ADENOMIOSIS: ¿MÁS ALLÁ DEL DOLOR PÉLVICO. QUÉ OTROS FACTORES DEBEMOS CONSIDERAR?
Alvear, A. (2025) · Revista Matronería Actual · doi:10.22370/revmat.1.2025.4498
Uiterweer, E. D. P., den Bosch, T. V., & Huirne, J. A. F. (2024) · doi:10.1007/978-90-368-3035-5_4
Mayangsari, N. H., Darmawi, D., Yusuf, M., Donel, S., Suhandri, W., Adikusuma, W., Suyanto, S., Frimayanti, N., & Fani, R. T. (2025) · Tropical Journal of Natural Product Research · doi:10.26538/tjnpr/v9i9.35
Han, N. Y., & Kim, S. H. (2025) · Springer eBooks · doi:10.1007/978-981-99-2955-9_7-1
Yang, Q., Zhang, J., & Fan, Z. (2024) · Figshare · doi:10.6084/m9.figshare.26308882
Yang, Q., Zhang, J., & Fan, Z. (2024) · Figshare · doi:10.6084/m9.figshare.26309100
Cao, Y., Li, C., & Ding, D. (2026) · BMC Women s Health · doi:10.1186/s12905-026-04332-2
“The exact pathogenesis remains incompletely understood, though recent studies suggest the involvement of multiple inflammatory factors, sex steroid hormone receptors, extracellular matrix enzymes, growth factors, and neuroangiogenic factors in disease development [3].”
Han, N. Y., & Kim, S. H. (2026) · Springer eBooks · doi:10.1007/978-981-95-2427-3_7
Ishizawa, C., Hiraoka, T., Aikawa, S., et al. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvag056
“Recently, a new hypothesis called endometrial–myometrial interface disruption (EMID) has been proposed to explain adenomyosis resulting from iatrogenic trauma to the endometrial–myometrial interface (EMI), describing the essential mechanisms underlying its pathogenesis [26, 27].”
Vervier, J., Squatrito, M., Blacher, S., Nisolle, M., & Munaut, C. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1750026
“Several pathogenetic frameworks have been proposed, including invagination of basalis endometrium across a disrupted junctional zone, metaplasia of Müllerian remnants or progenitor cells and endometrial-myometrial disruption (EMID) after iatrogenic injury (23, 24).”
Adenomyosis Pathophysiology, Diagnostic Advances, and Therapeutic Options
Kho, K. A., Gingold, J. A., & Shin, J. H. (2026) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000006276
Pocate-Cheriet, K. (2020) · theses.fr (ABES) · doi:10.70675/8a1fbb23z175dz4bbcz8427z6f4af93f23d1
Semenyna, H., Mandziy, I., Doroshenko-Kravchyk, M. V., Uhryn, O. M., & Коrytko, О. О. (2026) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.22.3.2026.1712
Tian, L., Wang, Y., Yang, M.-T., He, H.-N., He, T., Tang, Y., Lin, C., Hu, H.-Q., & Li, J. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1785229
“Adenomyosis, as a chronic gynecological disease with complex etiology and diverse clinical manifestations, creates an urgent need for patients to obtain information on its diagnosis, treatment, and impact on fertility (24, 25).”
Güzelbağ, B., Aydin, S., Ma, N. E., Selçuki, N. F. T., Oral, E., & Tuncer, F. N. (2026) · Biomedicines · doi:10.3390/biomedicines14071435
“Although frequently comorbid, the two conditions are now recognized as distinct entities with different underlying mechanisms [7–9].”
Clinical characteristics of different subtypes of adenomyosis in infertility
Wang, M., Li, N., Wang, J., Liu, Y., Wang, L. Y., & Shao, X. (2026) · Medicine · doi:10.1097/md.0000000000049441
Natural Killer Cells in Uterine Adenomyosis: Immunological Mechanisms and Therapeutic Perspectives
Yalikun, D., Si, L., Fu, H., & Guo, R. (2026) · Journal of Immunology Research · doi:10.1155/jimr/3833044
“Presently, the predominant mechanisms implicated in AM encompass the in fi ltration of the endometrial basal layer into the myometrium [22], alterations in embryonic origin transformation, and exter-nal inward invasion of endometrial cells [23, 24].”
MicroRNAs as Biomarkers for Adenomyosis: A Systematic Review
Buehler, P., Vidal, À., Vaineau, C., Karrer, T., & Mueller, M. (2026) · Biomedicines · doi:10.3390/biomedicines14081764
“Genetic and epigenetic modifications, such as progesterone receptor silencing and dysregulated estrogen receptor signaling, are also thought to contribute to disease onset, progression, and persistence [4,6,7].”
Hyperestrogenic imprinting and developmental origins of endometriosis and adenomyosis
Guo, S., & Viganò, P. (2026) · Human Reproduction Open · doi:10.1093/hropen/hoag075
“Additional support comes from animal experiments in which EMID procedures, designed to mimic uterine procedures in humans, successfully induce adenomyosis (Hao et al. , 2020; Elsherbini et al. , 2022; Guo et al. , 2025).”
Self-citationDonnez, J., Donnez, O., Taylor, H. S., Petraglia, F., Horne, A. W., Becker, C. M., Renner, S. P., Rius, M., Bestel, E., Stratopoulou, C. A., et al. (2026) · Reproduction and Fertility · doi:10.1530/raf-26-0075
A Rare Case of Mixed Mature Teratoma and Chocolate Cyst in an Infertile Woman
Sudiarta, K. E. (2026) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-2884
Rees, C. O., Gabriels, E., Weyers, S., Siebers, A. G., Westerhuis, M. E. M. H., Schoot, B. C., & van Vliet, H. (2026) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2026.115434
Gaia‐Oltean, A. I., Telecan, T., Pop, L., Pop, M. G., Badea, A. F., & Micu, R. (2026) · Healthcare · doi:10.3390/healthcare14193241
Shuai, X. U., & Xiao, R.-P. (2026) · Shengming kexue · doi:10.3724/cbls.2026116
Metadata
- Authors
- Guo, S.-W.
- Affiliations
- Fudan University (CN)
- Corresponding author
- Guo, Sun-Wei
- ORCID
- Guo, Sun-Wei
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2020-02-10
- Volume
- 9
- Issue
- 2
- Pages
- 485
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC7073526
- OpenAlex
- W3005308188
- Semantic Scholar
- 5a6ac6de5d69707a16c5a1e3292560d153248759
- Cited by
- 165
- References
- 116
- Citations by year
- 2026: 26 · 2025: 18 · 2024: 30 · 2023: 22 · 2022: 32 · 2021: 28 · 2020: 8
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Natural Science Foundation of China (81530040, 81771553)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
- Keywords
- adenomyosis, endometriosis, wound healing, hypoxia, epithelial-mesenchymal transition, bone marrow-derived stem cells, iatrogenic injury, perioperative interventions, deep infiltrating endometriosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review